Navigation Links
Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
Date:10/1/2013

LONDON, Oct. 1, 2013 /PRNewswire/ -- Considerable growth opportunities lie ahead for biopharmaceutical contract manufacturing organisations (CMOs). With blockbuster biologics worth over $100 billion due to lose patent protection by 2019, the global biosimilars market is projected to grow at a robust compound annual growth rate (CAGR) of 60.4 percent between 2012 and 2019.

A new market insight from Frost & Sullivan, Biopharmaceutical Contract Manufacturing, finds advances in bioprocessing technologies, as well as innovation in biopharmaceuticals production with transgenic plants and animals, stem cells and cloning, are likely to have a direct impact on the market.

"Due to the steep cost and long time needed to build, equip and validate a biomanufacturing facility, the majority of biopharmaceutical companies prefer leveraging the expertise of CMOs," notes Frost & Sullivan Healthcare Senior Research Analyst Aiswariya Chidambaram. "CMOs have made substantial investments in infrastructure, technology, and personnel in recent years, and are capable of providing uncomplicated, timely, and cost-effective services. They are also well versed with regulatory compliances and work closely with regulatory agencies, thereby reducing time-to-market."

Disposable technology is a key biomanufacturing trend and presents attractive opportunities for minimising production costs, owing to its customizable design, enhanced productivity, and significant operational benefits. Disposable equipment and single use bioreactors are considered a viable alternative to conventional stainless steel equipment, due to their flexibility, short start-up time, quick changeover between production campaigns, and absence of Clean in Place, Steam in Place, and large volumes of Water for Injection. Single use technologies are specially designed for multi-product contract manufacturing with additional benefits, such as simple transfer of operations betw
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
2. Bright Cluster Manager Named Bio-IT World Conference "Best in Show" Finalist
3. Distinct Bright Shares New Insight Which Homemade Cleaners are the Safest
4. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
5. DistinctBright Shares New Tips on How to Clean Pandora Bracelets with their Probiotic Cleaner
6. Distinct Bright Shares New Insights on How Cleaning Jewelry Might Be Destroying it
7. DistinctBright "The Best Probiotic Cleaner Company" Shares Tips for Green Cleaning
8. How to Do Spring Cleaning the Healthy Way: DistinctBright Explores the Overlooked Dangers of Household Cleaning Products and offers Natural Cleaning Solutions
9. Distinct Bright Answers Questions on Why Bacteria are Becoming Resistant to Antibiotics
10. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
11. Elsevier and the Dutch Fulbright Center Start Collaboration to Support Early Career Researchers in the Netherlands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... According to a new market report published by ... was valued at USD 3,754.6 million in 2012 and is ... a CAGR of 5.9% from 2013 to 2019. , Nearly ... afflicted by bone and joint disorders, and this number is ... and will continue to increase the demand for orthobiologics. Other ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 Pittcon ... Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have ... on September 5, 2014. JASIS , Asia’s largest ... 3-5, 2014, in Makuhari Messe, Japan. , The ... Tools for Bioanalysis from Single Molecules to Single Cells” ...
(Date:8/29/2014)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") ... for the six months ended June 30, 2014. ... dollars and presented under International Financial Reporting Standards ... , Announced top-line results related to the ... subjects enrolled in the Phase 2 iDEAL Study ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Only Collagen-Based Filler Proven To Last Through One Year , ... Ortho Dermatologics today announced that the U.S. Food and Drug ... safety data through 12 months for EVOLENCE(R), a collagen-based dermal ... and folds, such as nasolabial folds. , , To ...
... RAMAT GAN, Israel, June 8 EarlySense announced ... cleared for,marketing by the U.S. Food and Drug Administration ... Dutch notified body, in accordance with the,EC-Directive 93/42/EEC. Both ... home, hospital or clinical setting. In November 2007, EarlySense,announced ...
... under the Pacific Ocean, could provide a powerful clean-up ... issue of the journal, Microbiology , Professor Gejiao ... Wuhan, PR China describe how a particular strain of ... effective in removing manganese from solutions, converting it into ...
Cached Biology Technology:Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler 2Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler 3Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler 4EarlySense's EverOn(TM) System Receives FDA Clearance and CE Mark Certification 2
(Date:8/28/2014)... Researchers at the University of Minnesota have developed ... to be used for muscle regeneration research as well ... FSHD. , The research is published in the current ... There is no treatment for FSHD, which is thought ... muscular dystrophy. FSHD is an unusual genetic disorder because, ...
(Date:8/28/2014)... peer groups and clinicians is critical to the ... University of Georgia research. , A qualitative study ... determined that role models for successful breastfeeding help ... , "Mothers who received that support are more ... co-author Alex Anderson, an associate professor in the ...
(Date:8/28/2014)... DENVER , Aug. 28, 2014  Privacy Advocate ... (EFF), Jennifer Lynch , joins the lineup of ... the second annual Biometrics UnPlugged Executive Summit in ... Previously announced speakers include Steven Rahman, Director, ... President, Public Sector at Experian. The theme of this ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Breastfeeding study shows need for effective peer counseling programs 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
... that some brain tumours in larvae of the fruit fly ... cells to grow. The removal of some of these genes ... are crucial for tumour development. The study, headed by ICREA ... Science . One of the characteristics of ...
... mankind,s migration from Africa to the New World, and the ... international study that for the first time will dig deep ... a mile) down under 300 meters (about a fifth of ... researchers will look back in time to collect a massive ...
... University of Exeter have developed a new approach to ... up the process of finding vaccines. Dr Andrea ... the university,s Cornwall Campus, has pioneered a simple screen ... gene structures of pathogenic* bacteria. The screen allows ...
Cached Biology News:Some brain tumors mimic the genetic program of germline cells 2Back to the dead (sea, that is) 2Finding new ways to tackle environmental diseases 2
... formulated for non-denaturing polyacrylamide and agarose gel ... solution contains a bromophenol blue tracking dye ... sample loading. EDTA has been included to ... SDS has been added to help dissociate ...
... Antibody Description: ... antibody. Detects 70 kDa YAP from ... and immunohistochemistry. ... Storage: -20C ...
...
... M-PER Mammalian Protein Extraction ... cell lysis solution that means ... and no sonication! With M-PER ... just five minutes at room ...
Biology Products: